Centralized Patient Outreach for Lung Cancer Screening
(CLEAR Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines how centralized outreach can increase the completion of lung cancer screenings. It focuses on current or former smokers who haven't recently had a specific type of lung scan. The trial includes two groups: one receives extra outreach (such as phone calls or mail), while the other receives usual care. Potential participants include patients at Ryan Health in New York City who have not been diagnosed with lung cancer. As an unphased trial, this study provides a unique opportunity to contribute to research that could enhance lung cancer screening processes for many.
Do I need to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to check with the trial coordinators for specific guidance.
What prior data suggests that centralized patient outreach for lung cancer screening is safe?
Studies have shown that directly reaching out to patients can effectively increase lung cancer screening rates. This method is safe, using simple communication like phone calls and mail, which are non-invasive.
Research indicates that these outreach programs help more people adhere to their lung cancer screening schedules without harm. No reports of negative effects from the outreach itself suggest that this approach is safe and well-received by participants.12345Why are researchers excited about this trial?
Researchers are excited about centralized patient outreach for lung cancer screening because it offers a proactive approach to early detection. Unlike standard care, which relies on patients initiating screenings, this method actively reaches out to individuals to encourage timely lung cancer screenings. By potentially increasing screening rates, this outreach can lead to earlier diagnoses and better outcomes for patients, which is a promising advancement in lung cancer management.
What evidence suggests that centralized patient outreach is effective for lung cancer screening?
Research has shown that centralized patient outreach can significantly increase lung cancer screening rates. In this trial, individuals in the outreach arm will receive centralized patient outreach for lung cancer screening in addition to usual care. One study found that a health system doubled its lung cancer screening rates using CT scans by directly contacting patients. Another study discovered that these centralized programs help individuals adhere to yearly screenings, allowing for earlier detection of lung cancer. Specifically, one program found 77.8% of its lung cancer cases at an early stage. Centralized outreach not only boosts screening rates but also aids in earlier detection, which is crucial for effective treatment.678910
Who Is on the Research Team?
Jialin Mao, MD, PhD
Principal Investigator
Weill Medical College of Cornell University
Bradley B Pua, MD
Principal Investigator
Weill Medical College of Cornell University
Are You a Good Fit for This Trial?
This trial is for individuals who are eligible for lung cancer screening, typically due to a history of smoking or other risk factors. They must be served by Federally Qualified Health Centers. Specific inclusion and exclusion criteria details were not provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Outreach
Centralized patient outreach through a letter followed by up to three attempts of telephone contact for lung cancer screening
Follow-up
Participants are monitored for follow-up care, including biopsy or lung cancer treatment
What Are the Treatments Tested in This Trial?
Interventions
- Centralized patient outreach for lung cancer screening
Find a Clinic Near You
Who Is Running the Clinical Trial?
Weill Medical College of Cornell University
Lead Sponsor